China Health Group Inc.
China Health Group Inc. 8225.HK Peers
See (8225.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 8225.HK | HK$0.17 | -1.79% | 164.2M | 8.25 | HK$0.02 | N/A |
| 2359.HK | HK$79.70 | +1.59% | 216.2B | 18.62 | HK$4.28 | +2.11% |
| 2268.HK | HK$44.80 | +0.56% | 53.9B | 49.23 | HK$0.91 | N/A |
| 3347.HK | HK$41.00 | -2.38% | 44.7B | 97.62 | HK$0.42 | +0.87% |
| 6127.HK | HK$16.14 | +0.88% | 16B | 28.82 | HK$0.56 | +1.20% |
| 2325.HK | HK$3.50 | -0.28% | 2B | -2.41 | -HK$1.45 | +0.62% |
| 6667.HK | HK$7.20 | -0.69% | 1.6B | 42.35 | HK$0.17 | N/A |
| 8037.HK | HK$0.67 | -1.49% | 653.7M | -3.35 | -HK$0.20 | N/A |
| 0928.HK | HK$0.10 | -12.28% | 185M | 10.00 | HK$0.01 | N/A |
Stock Comparison
8225.HK vs 2359.HK Comparison
8225.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8225.HK stands at 164.2M. In comparison, 2359.HK has a market cap of 216.2B. Regarding current trading prices, 8225.HK is priced at HK$0.17, while 2359.HK trades at HK$79.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8225.HK currently has a P/E ratio of 8.25, whereas 2359.HK's P/E ratio is 18.62. In terms of profitability, 8225.HK's ROE is -0.18%, compared to 2359.HK's ROE of +0.19%. Regarding short-term risk, 8225.HK is less volatile compared to 2359.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8225.HK.